← FDA Drug Approvals (Drugs@FDA)
SODIUM NITROPRUSSIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2020-10-29
Drug application
- FDA Application #
ANDA211277- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM NITROPRUSSIDE
- Generic name
- Sodium Nitroprusside
- Active ingredients
- SODIUM NITROPRUSSIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- XIROMED
- First approval
- 2020-10-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown